Antonio Jimeno
Professor, Medicine-Medical Oncology · University of Colorado
Credentials: · · ·
History
Present
- Until 2006
Johns Hopkins University School of Medicine Program
- Until 2003
- Until 2000
- 1998
University of Valladolid School of Medicine
Research
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Science · 2008 · 3,159 citations
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 1,128 citations
Patient-derived tumour xenografts as models for oncology drug development
Review · Nature Reviews Clinical Oncology · 2012 · 1,030 citations
51 papers · 36 as a fellow
41 papers
30 papers · 14 as a fellow
- DR
David Raben
19 papers
16 papers
15 papers · 9 as a resident
14 papers · 4 as a fellow
14 papers
Grants
- 2026–2031
National Institute of Dental and Craniofacial Research · R01
Contact PI · $552K · University of Colorado Denver
- 2010–2030
National Cancer Institute · R01
Contact PI · $5.6M · University of Colorado Denver
- 2019–2030
Cell Immunotherapy and Experimental Therapeutics Program (CIETP).
National Cancer Institute · T32
Contact PI · $2M · University of Colorado Denver
- 2021–2027
Colorado Head and Neck Cancer SPORE
National Cancer Institute · P50
Contact PI · $10.1M · University of Colorado Denver
Clinical trials
- 2015–2025
Principal investigator · Completed
University of Colorado, Denver
- 2014–2015
Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors
Principal investigator · Terminated · Phase 1
Traws Pharma, Inc.
- 2011–2013
Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer
Principal investigator · Completed · Phase 1
University of Colorado, Denver
- 2014–2015
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Study chair · Completed · Phase 1
Traws Pharma, Inc.